UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect
PLEASANTON, Calif., Oct. 10, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq:TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC") has declined to issue a second preliminary injunction against NanoString Technologies, Inc. (Nasdaq:NSTG) based on European Patent 2 794 928 B1 ("the EP 928 patent," docket No 459996/2023). However, the injunctions granted by the Regional Court Munich I in May and by the UPC in September both remain in full force and effect and are not affected by today's decision in terms of scope or duration.
Read more at prnewswire.com
/Apple%20watch%20on%20wrist%20by%20fancycrave1%20via%20Pixabay.jpg)
/Tesla%20charging%20station%20black%20background%20by%20Blomst%20via%20Pixabay.jpg)